January | February | March | April | May | June | July | August | September | October | November | December December - 2006 Biotech Company Pharma Company Type/Product Area Terms/Details Acadia Pharmaceuticals Inc. (ACAD) Ipsen SA (France) Acadia licensed certain technology designed to add to its serotonin platform The nonexclusive license complements Acadia's existing program; Ipsen gets $0.25M up front, along with potential milestone and royalty payments Affymetrix Inc. (AFFX
January | February | March | April | May | June | July | August | September | October | November | December COMPLETED MERGERS AND ACQUISITIONS - December 2006 Company Acquired Acquired By Or Merged With Date Announced Date Completed Value (M) Terms/Details Connetics Corp. (CNCT) Stiefel Laboratories Inc. 10/23/06 12/28/06 $670 Stiefel paid $17.50 per share in cash, or $670M, for Connetics; the offer was a 62% premium to the four-week average price Elbion AG (Germany
The funding plan follows a licensing deal disclosed Monday with GE Healthcare, a unit of GE Co., of Fairfield, Conn., worth up to €28 million (US$33.8 million), which involves marketing rights to PhotoCure's Hexvix optical imaging agent for the diagnosis and monitoring of bladder cancer...The deal gives GE Healthcare exclusive marketing and distribution rights outside of the U.S
BioWorld International | Wednesday, January 11, 2006
CytoGenix Inc., of Houston, signed a contract with the Fast Trak BioDefense group of St. Giles, UK-based GE Healthcare, a $14 billion unit of General Electric Co
Biotech Co.* (Country; Symbol) Pharma Co. (Country) Type/Product Area Terms/Details (Date) Affectis Pharmaceuticals AG* (Germany) NV Organon (the Netherlands) Affectis will apply its technologies to the validation of gene targets in depression and anxiety Terms of the deal were not disclosed (11/2) Affibody AB* (Sweden) Asahi Kasei Corp. (Japan) Affibody will develop a product for the removal of a target molecule from fluid mixtures Asahi Kasei intends to develop a medical device
Cellartis is conducting the work internally and through collaboration with academic partners and with GE Healthcare subsidiary Amersham Biosciences AB, of Uppsala, Sweden
By Cormac Sheridan | BioWorld International | Wednesday, December 14, 2005
Saneron CCEL Therapeutics Inc., of Tampa Bay, Fla., and Chalfont St. Giles, UK-based GE Healthcare, a unit of General Electric Co. ,signed a research and development agreement to optimize GE Healthcare's Ficoll-Paque for the isolation of stem cells from umbilical cord blood
Managing Editor Ribonucleic acid interference (RNAi) has grown from a curiosity, outlived its hype and has emerged as a sound market that has revolutionized biotechnology research and is proceeding toward the ultimate goal of producing effective marketed therapeutics for treatment of a variety of disease targets. RNAi has achieved credibility as a research tool in scientific, laboratory, and now, clinical, applications and has been the breadwinner for its market while the therapeutics sector
By Michael J. Harris | RNAi Report | Monday, November 7, 2005
terms were not disclosed (9/30) Imcor Pharmaceutical Co. (PK:ICPH) and Alliance Pharmaceutical Corp. (OTC BB:ALLP) GE Healthcare (UK) They resolved disputed patent claims covering ultrasound contrast agents GE Healthcare will pay $1M to Imcor and $200,000 to Alliance in license fees
Ltd. (Japan) Funakoshi will promote and distribute Affibody research reagents in Japan Terms of the deal were not disclosed (10/4) Alpha Innotech Corp.* GE Healthcare (UK) Alpha Innotech will develop a line of imaging systems for GE The products will be sold worldwide under the GE brand...terms of the deal were not disclosed (9/2) Ambion Inc.* GE Healthcare (UK) GE will manufacture microRNA microarrays for Ambion GE will use its CodeLink Bioarray technology in the license supply agreement
Ambion Inc., of Austin, Texas, and UK-based GE Healthcare, a unit of General Electric Co., entered a license and supply agreement under which GE Healthcare will manufacture for Ambion microRNA microarrays using its CodeLink Bioarray technology
Imcor Pharmaceutical Co., of San Diego, Alliance Pharmaceutical Corp., also of San Diego, and its wholly owned subsidiary, Molecular Biosystems Inc., concluded an agreement with GE Healthcare Ltd., of Chalfont St. Giles, UK, to resolve claims in a patent dispute
Alpha Innotech Corp., of San Leandro, Calif., entered a license and supply agreement with UK-based GE Healthcare to develop, manufacture and supply a line of imaging systems to GE
terms were not disclosed (7/18) Gene Logic Inc. (GLGC) GE Healthcare Deal under which GE will distribute Gene Logic's Sciantis System worldwide The product is an an online gene expression analysis system
Gene Logic Inc. , of Gaithersburg, Md., signed an agreement with GE Healthcare for global distribution of its Sciantis System, an online gene-expression analysis system developed for use by academic, government and other nonprofit research organizations
Biotech Co.* (Country; Symbol) Pharma Co. (Country) Type/Product Area Terms/Details (Date) FIRST QUARTER Accelrys Inc. (ACCL) Henkel KGaA (Germany) Three-year license deal under which Henkel will use Accelrys' Materials Studio software The deal builds on a relationship in which Henkel was a member of Accelrys' Formulations Consortium to develop software solutions; terms were not disclosed (3/9) Access Pharmaceuticals Inc. (AMEX:AKC) Wyeth Consumer Healthcare Agreement granting Wyeth
State of the Industry Report | Tuesday, May 10, 2005
Biotech Co.* (Country; Symbol) Pharma Co. (Country) Product Terms/Details (Date) FIRST QUARTER AEterna Laboratories Inc. (Canada; TSE:AEL) Produtos Roche QFSA (Brazilian unit of Roche) Deal for the marketing in Brazil of Impavido (miltefosine), an oral therapy for leishmaniasis Roche will support AEterna unit Zentaris GmbH in registration efforts in Brazil, and would market the product there; terms were not disclosed (2/2) Atria Genetics Inc.* Abbott Laboratories For tests that define
State of the Industry Report | Tuesday, May 10, 2005
it also would get royalties on any sales (12/16) Qiagen NV (the Netherlands; QGEN) Roche Molecular Systems Roche will market Qiagen's media sample preparation kits under its AmpliLute trademark Terms of the deal were not disclosed (2/9) Repligen Corp. (RGEN) GE Healthcare They amended 1999 supply agreement covering the manufacture of GE's recombinant Protein A The agreement was extended through 2010, and expanded to include an additional GE protein (2/8) Savient Pharmaceuticals
Repligen Corp. , of Waltham, Mass., amended its 1999 supply agreement with GE Healthcare, of Waukesha, Wis., governing the manufacture of GE Healthcare's recombinant protein A. The amendment extends the term of the agreement through 2010, expands the manufacturing to include an additional GE Healthcare protein and anticipates a mechanism for the manufacturing of future proteins
January | February | March | April | May | June | July | August | September | October | November | December December - 2006 Biotech Company Pharma Company Type/Product Area Terms/Details Acadia Pharmaceuticals Inc. (ACAD) Ipsen SA (France) Acadia licensed certain technology designed to add to its serotonin platform The nonexclusive license complements Acadia's existing program; Ipsen gets $0.25M up front, along with potential milestone and royalty payments Affymetrix Inc. (AFFX